Today, the Trump administration released a final rule on Health Reimbursement Arrangements (HRAs).
House Speaker Pelosi’s Bizarre Drug Price Negotiation Plan
Speaker Nancy Pelosi (D-Calif.) is expected to soon release her long-awaited drug pricing proposal. According to news reports, the plan is expected to require the Department of Health and Human Services (HHS) to directly “negotiate” with pharmaceutical manufacturers for an “acceptable” price for at least 25 drugs that would apply to the entire U.S. market. […]
CAGW Joins Coalition to Fight Against Socialized Medicine
Today, conservative organizations announced and launched the “Coalition Against Socialized Medicine” to fight to protect our most precious asset, our health.
No, AOC – Tornados in D.C. Are Not Another Sign of Global Warming
Rep. Alexander Ocasio-Cortez (D-NY), never lacking for a fun sound bite, released an anxiety-ridden Instagram over a tornado warning that was issued in Washington, D.C. at about 3:50 pm on May 23. Welcome to Washington Congresswoman! You will soon learn that severe thunderstorms during summer afternoons are practically a daily occurrence and tornado warnings are […]
U.S. Should Not Import Foreign Price Controls on Drugs
Adopting other countries’ drug pricing severely damage to innovation and developing new cures.
Fake News on Healthcare Legislation Coming Your Way Soon
Later this week, Speaker Nancy Pelosi (D-Calif.) will have a floor vote on H.R. 986, deceitfully called the, “Protecting Americans with Preexisting Conditions Act of 2019.” The legislation, if it were to be implemented, would reverse some of the Trump administration’s efforts to stabilize the individual health insurance markets that have been upended and grown […]
Conservatives Behaving Badly on Drug Pricing
Conservative politicians like to say they are for free markets, competition, and property rights to promote innovation and lower prices of goods. But when it comes to pharmaceuticals, too many of them go careening off the freedom road to promote socialist policies. They fail to recognize the years of expensive clinical trials and complicated protocols, […]
Binding Arbitration for Medicare Part B: Price Controls by Another Name
The Trump administration proposed using an International Pricing Index in October 2018 to reimburse providers for drugs administered under Medicare Part B. These drugs require the involvement of a physician and include, but are not limited to, infused and injectable drugs, some antigens, drugs used with durable medical equipment, and blood clotting factors. Instead of […]
Same Old, Same Old
Sen. Bernie Sanders (i-Vt) re-introduced his “Medicare for All” bill, S. 1129 on April 10 and as of today, the legislation has 14 cosponsors, five of which who are Democratic presidential primary contenders: Sens. Cory Booker (D-N.J), Kristen Gillibrand (D-N.Y.), Kamala Harris (D-Calif.), Elizabeth Warren (D-Mass.) and of course, Bernie himself. Its companion bill in […]
Higher Taxes on Pharmaceuticals Will Not Solve the Opioid Crisis
It is common knowledge that addiction to opioids and other controlled substances such as fentanyl is a national epidemic that needs to be addressed. But, the plans being offered by Minnesota Governor Tim Waltz and the state legislature will drive up pharmaceutical costs, hurt patients, and fail to solve the opioid crisis in Minnesota. The […]